An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military



Status:Active, not recruiting
Conditions:Psychiatric, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:12/7/2018
Start Date:February 12, 2018
End Date:September 2019

Use our guide to learn which trials are right for you!

It is urgent to make evidence-based treatments (EBTs) for military personnel readily
accessible in order to meet the growing demand for effective and efficient treatment for
posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are
available, but barriers to accessing care can deter military personnel from receiving
treatment. Web-treatments represent an innovative way to overcome these barriers. The
efficacy of previously developed web-treatments for PTSD appear promising, however, they are
not based on treatment protocols with strong empirical support for their efficacy. No study
to date has examined web-treatment of PTSD using a well-established treatment program.

The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of
Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military
personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be
consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment
and 1- and 3-months after treatment completion.


Inclusion Criteria:

- Active-duty military personnel and veterans who have deployed post 9/11

- Seeking treatment for PTSD

- Significant PTSD symptoms as determined by a PCL-5 score greater than or equal to 31

- Has experienced a Criterion A event that is a specific combat-related event or high
magnitude operational experience that occurred during a period of recent military
deployment

- Able to speak and read English and access to an internet-connected computer

- Indication that the participant plans to be able to participant in the study for the
next three months following the first assessment

Exclusion Criteria:

- Diagnosis of bipolar disorder or psychotic disorder, as determined by participant
self-report)

- Current substance dependence, as determined by participant self-report)

- Diagnosis of a moderate or severe traumatic brain injury, as determined by participant
self-report)

- Current suicidal ideation severe enough to warrant immediate attention, as determined
by participant self-report)

- Currently engaged in evidence-based treatment for PTSD (e.g. Prolonged Exposure
Therapy or Cognitive Processing Therapy), as determined by participant self-report.
We found this trial at
2
sites
4502 Medical Drive
San Antonio, Texas 78284
(210) 567-7000
Phone: 210-562-6704
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials